Re-Treatment Study of Probuphine in Opioid Addiction

Clinical trial NCT01262261 · COMPLETED

Trial details

NCT number: NCT01262261
Sponsor: Titan Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Opioid Dependency

Start date: 2010-11-01
Primary completion: 2011-11-01
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.